News

Earlier this week, AWAK Technologies (AWAK), a Singapore-headquartered medical technology company focused on dialysis using regeneration technology for end-stage renal disease, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to its AWAK Peritoneal Dialysis (AWAK PD) device, a wearable and ultra-portable PD system that incorporates AWAK’s patented sorbent technology.

Launched in 2010 with a $25 million Series A financing led by Third Rock Ventures, Foundation Medicine released its first commercial assay called FoundationOne in 2012.

.

.

.

Users will be able to make refill requests, locate pharmacies, and even chat with a pharmacist without leaving Propeller's app.

Also: Pritzker Group Venture Capital announces slew of promotions and Grand Rounds taps former USF chief medical officer Dr. Ami Parekh for same role. 

Tivic Health Systems’ ClearUP Sinus Pain Relief uses low current electrical waves to stimulate nerves beneath the skin.

The partners plan on starting with mental health screening tools for ADHD, depression, PTSD, as well as setting up protocals for other conditions. 

Alongside device support, the Philips Cares app offers caretakers shared reminders, access to emergency services and data analysis features.